Alive N = 63 |
Dead N = 11 |
Age-adjusted HR (95% CI) |
Fully adjusted* HR (95% CI) | P | |
---|---|---|---|---|---|
Vagina | |||||
No | 52 (82.5%) | 11 (100.0%) | |||
Yes | 11 (17.5%) | 0 (0%) | |||
Pelvic lymph node | |||||
No | 53 (84.1%) | 9 (81.8%) | 1.00 | 1.00 | |
Yes | 10 (15.9%) | 2 (18.2%) | 0.64 (0.12, 3.31) | 0.22 (0.02, 2.43) | 0.22 |
Pelvis | |||||
No | 48 (76.2%) | 8 (72.7%) | 1.00 | 1.00 | |
Yes | 15 (23.8%) | 3 (27.3%) | 1.06 (0.28, 4.02) | 1.41 (0.15, 13.1) | 0.76 |
Para-aortic lymph node | |||||
No | 48 (76.2%) | 8 (72.7%) | 1.00 | 1.00 | |
Yes | 15 (23.8%) | 3 (27.3%) | 0.46 (0.11, 1.93) | 0.37 (0.04, 3.16) | 0.36 |
Extraperitoneal | |||||
No | 31 (49.2%) | 2 (18.2%) | 1.00 | 1.00 | |
Yes | 32 (50.8%) | 9 (81.8%) | 3.26 (0.69, 15.4) | 10.9 (0.42, 285) | 0.15 |
Abdomen | |||||
No | 39 (61.9%) | 7 (63.6%) | 1.00 | 1.00 | |
Yes | 24 (38.1%) | 4 (36.4%) | 1.46 (0.39, 5.43) | 1.19 (0.16, 8.87) | 0.86 |
*Adjusted for age (continuous), year of surgery (continuous), lymph nodes (PLN and PALN), histology (endometrioid/mixed, clear cell, and papillary serous), lymphovascular invasion, and myometrial invasion.